Electromed, Inc. (ELMD)

Market Cap	247.06M
Revenue (ttm)	57.06M
Net Income (ttm)	6.47M
Shares Out	8.46M
EPS (ttm)	0.72
PE Ratio	40.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	138,981
Open	28.00
Previous Close	27.92
Day's Range	28.00 - 29.62
52-Week Range	9.81 - 30.00
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About ELMD

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway Syst...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 13, 2010
• Employees: 174
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: ELMD
• Website: https://smartvest.com

Financial Performance

In 2024, Electromed's revenue was $54.72 million, an increase of 13.83% compared to the previous year's $48.07 million. Earnings were $5.15 million, an increase of 62.67%.